Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1987 2
1988 1
1990 4
1991 10
1992 14
1993 20
1994 18
1995 45
1996 31
1997 58
1998 78
1999 111
2000 109
2001 139
2002 185
2003 192
2004 215
2005 228
2006 272
2007 303
2008 331
2009 350
2010 420
2011 474
2012 482
2013 646
2014 671
2015 706
2016 724
2017 716
2018 728
2019 727
2020 402
Text availability
Article attribute
Article type
Publication date

Search Results

8,411 results
Results by year
Filters applied: . Clear all
Page 1
Inflammatory Bowel Disease: Pathophysiology and Current Therapeutic Approaches.
Abraham BP, Ahmed T, Ali T. Abraham BP, et al. Handb Exp Pharmacol. 2017;239:115-146. doi: 10.1007/164_2016_122. Handb Exp Pharmacol. 2017. PMID: 28233184 Review.
Inflammatory bowel diseases, most commonly categorized as Crohn's disease and ulcerative colitis, are immune mediated chronic inflammatory disorders of the gastrointestinal tract. ...In the end, therapeutic algorithms for both diseases ar
Inflammatory bowel diseases, most commonly categorized as Crohn's disease and ulcerative colitis, are immune med
Inflammatory Bowel Disease.
Lichtiger S. Lichtiger S. Gastrointest Endosc Clin N Am. 2019 Jul;29(3):xv-xvi. doi: 10.1016/j.giec.2019.03.002. Epub 2019 Apr 12. Gastrointest Endosc Clin N Am. 2019. PMID: 31078255 No abstract available.
Inflammatory bowel disease and the elderly: a review.
Taleban S, Colombel JF, Mohler MJ, Fain MJ. Taleban S, et al. J Crohns Colitis. 2015 Jun;9(6):507-15. doi: 10.1093/ecco-jcc/jjv059. Epub 2015 Apr 13. J Crohns Colitis. 2015. PMID: 25870198 Review.
Inflammatory bowel disease among the elderly is common, with growing incident and prevalence rates. Compared with younger IBD patients, genetics contribute less to the pathogenesis of older-onset IBD, with dysbiosis and dysregulation of the immune system play
Inflammatory bowel disease among the elderly is common, with growing incident and prevalence rates. Compared with young
Intestinal Permeability in Inflammatory Bowel Disease: Pathogenesis, Clinical Evaluation, and Therapy of Leaky Gut.
Michielan A, D'Incà R. Michielan A, et al. Mediators Inflamm. 2015;2015:628157. doi: 10.1155/2015/628157. Epub 2015 Oct 25. Mediators Inflamm. 2015. PMID: 26582965 Free PMC article. Review.
The pathogenesis of inflammatory bowel disease (IBD) is multifactorial with data suggesting the role of a disturbed interaction between the gut and the intestinal microbiota. ...Antitumor necrosis factor-α (TNF-α) therapy reduces mucosal inflamm …
The pathogenesis of inflammatory bowel disease (IBD) is multifactorial with data suggesting the role of a disturbed int …
Induction and maintenance treatment of inflammatory bowel disease: A comprehensive review.
Jeong DY, Kim S, Son MJ, Son CY, Kim JY, Kronbichler A, Lee KH, Shin JI. Jeong DY, et al. Autoimmun Rev. 2019 May;18(5):439-454. doi: 10.1016/j.autrev.2019.03.002. Epub 2019 Mar 4. Autoimmun Rev. 2019. PMID: 30844556 Review.
Ulcerative colitis (UC) and Crohn's disease (CD) are the two major types of inflammatory bowel disease (IBD). We conducted a comprehensive review of meta-analyses to summarize the reported effectiveness of different drugs for IBD. ...
Ulcerative colitis (UC) and Crohn's disease (CD) are the two major types of inflammatory bowel disease (IBD). We …
Molecular mechanism of action of anti-tumor necrosis factor antibodies in inflammatory bowel diseases.
Billmeier U, Dieterich W, Neurath MF, Atreya R. Billmeier U, et al. World J Gastroenterol. 2016 Nov 14;22(42):9300-9313. doi: 10.3748/wjg.v22.i42.9300. World J Gastroenterol. 2016. PMID: 27895418 Free PMC article. Review.
Anti-tumor necrosis factor (TNF) antibodies are successfully used in the therapy of inflammatory bowel diseases (IBD). However, the molecular mechanism of action of these agents is still a matter of debate. ...Furthermore, the anti-TNF ag …
Anti-tumor necrosis factor (TNF) antibodies are successfully used in the therapy of inflammatory bowel
Skin Manifestations of Inflammatory Bowel Disease.
Greuter T, Navarini A, Vavricka SR. Greuter T, et al. Clin Rev Allergy Immunol. 2017 Dec;53(3):413-427. doi: 10.1007/s12016-017-8617-4. Clin Rev Allergy Immunol. 2017. PMID: 28643285 Review.
Inflammatory bowel disease (IBD) with its two main subtypes Crohn's disease and ulcerative colitis is not restricted to the gastrointestinal tract. ...The pathophysiology of EIMs remains elusive, although data from clinical trials demonstrating anti-
Inflammatory bowel disease (IBD) with its two main subtypes Crohn's disease and ulcerative colitis is not restri
Inflammatory bowel disease.
Podolsky DK. Podolsky DK. N Engl J Med. 2002 Aug 8;347(6):417-29. doi: 10.1056/NEJMra020831. N Engl J Med. 2002. PMID: 12167685 Review. No abstract available.
Management of Inflammatory Bowel Disease: Progress and Promise.
Lightdale CJ. Lightdale CJ. Gastrointest Endosc Clin N Am. 2019 Jul;29(3):xiii-xiv. doi: 10.1016/j.giec.2019.03.003. Gastrointest Endosc Clin N Am. 2019. PMID: 31078254 No abstract available.
Pregnant women with inflammatory bowel disease: the effects of biologicals on pregnancy, outcome of infants, and the developing immune system.
Wieringa JW, Driessen GJ, Van Der Woude CJ. Wieringa JW, et al. Expert Rev Gastroenterol Hepatol. 2018 Aug;12(8):811-818. doi: 10.1080/17474124.2018.1496820. Epub 2018 Jul 12. Expert Rev Gastroenterol Hepatol. 2018. PMID: 29972674 Review.
Relapse of inflammatory bowel disease (IBD) during conception and pregnancy has been associated with a negative pregnancy outcome. ...Areas covered: A literature search was performed using the following search terms: inflammatory bowel diseas
Relapse of inflammatory bowel disease (IBD) during conception and pregnancy has been associated with a negative pregnan …
8,411 results
Jump to page
Feedback